Epstein-Barr virus (EBV)-associated lymphoid proliferations, a 2018 update
- 1 September 2018
- journal article
- research article
- Published by Elsevier BV in Human Pathology
- Vol. 79, 18-41
- https://doi.org/10.1016/j.humpath.2018.05.020
Abstract
No abstract availableKeywords
This publication has 147 references indexed in Scilit:
- T-Cell Non-Hodgkin's Lymphomas Reported to the FDA AERS With Tumor Necrosis Factor-Alpha (TNF-α) Inhibitors: Results of the REFURBISH StudyAmerican Journal Of Gastroenterology, 2013
- The genetic landscape of mutations in Burkitt lymphomaNature Genetics, 2012
- IG/MYC Rearrangements are the Main Cytogenetic Alteration in Plasmablastic LymphomasThe American Journal of Surgical Pathology, 2010
- Epstein–Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8–9 September 2008Annals Of Oncology, 2009
- Peripheral T-cell Lymphomas With a Follicular Growth Pattern are Derived From Follicular Helper T Cells (TFH) and may Show Overlapping Features With Angioimmunoblastic T-cell LymphomasThe American Journal of Surgical Pathology, 2009
- The Intersection of Epstein-Barr Virus with the Germinal CenterJournal of Virology, 2009
- Epstein-Barr Virus Inhibits Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication in Primary Effusion LymphomasJournal of Virology, 2007
- Three restricted forms of Epstein–Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cellsProceedings of the National Academy of Sciences of the United States of America, 2006
- Epstein-Barr virus: exploiting the immune systemNature Reviews Immunology, 2001
- VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMAThe Lancet, 1964